可除颤心律院内心搏骤停患者除颤前使用肾上腺素:倾向匹配分析
该倾向匹配分析基于2000-2018年美国心脏协会Get With The Guidelines-Resuscitation登记中497家医院的数据,纳入18岁以上、初始可除颤心律并接受除颤的院内心搏骤停成人。在34 820例患者中,7054例(20.3%)在首次除颤前接受了肾上腺素,违背现行指南。倾向匹配分析(6569对)显示,除颤前使用肾上腺素与出院存活(22.4% vs 29.7%;aOR 0.69;95%CI 0.64-0.74;P<0.001)、神经功能良好存活(15.8% vs 21.6%;aOR 0.68;95%CI 0.61-0.76;P<0.001)及急性复苏后存活(61.7% vs 69.5%;aOR 0.73;95%CI 0.67-0.79;P<0.001)的 odds 更低相关。作者结论认为,除颤前使用肾上腺素与更差的存活结局相关。
要点
- 在34 820例初始可除颤心律的院内心搏骤停成人中,7054例(20.3%)在首次除颤前使用了肾上腺素,与现行指南优先立即除颤相悖。
- 除颤前使用肾上腺素与除颤延迟相关(中位数4分钟 vs 0分钟)。
- 倾向匹配分析(6569对)显示,除颤前使用肾上腺素与出院存活率更低相关(22.4% vs 29.7%;aOR 0.69;95%CI 0.64-0.74;P<0.001)。
- 神经功能良好存活率亦更低(15.8% vs 21.6%;aOR 0.68;95%CI 0.61-0.76;P<0.001),急性复苏后存活率更低(61.7% vs 69.5%;aOR 0.73;95%CI 0.67-0.79;P<0.001)。
- 上述关联在多项敏感性分析中一致,包括按除颤时间匹配的分析。
适用人群与场景
- 美国心脏协会Get With The Guidelines-Resuscitation登记中497家医院2000-2018年数据。
- 纳入18岁及以上、初始可除颤心律并接受除颤的院内心搏骤停成人。
研究设计与关键结果
- 研究设计:倾向匹配分析,使用2000-2018年497家医院登记数据。
- 人群:34 820例初始可除颤心律的院内心搏骤停成人,其中7054例(20.3%)在除颤前接受肾上腺素。
- 与除颤优先组相比,肾上腺素优先组较少有心肌梗死或心力衰竭病史,更多有肾功能衰竭、脓毒症、呼吸功能不全以及在院内心搏骤停前接受机械通气(标准化差异均>10%)。
- 除颤前使用肾上腺素与除颤延迟相关(中位数4分钟 vs 0分钟)。
- 倾向匹配分析(6569对)中,除颤前使用肾上腺素与出院存活 odds 更低相关(22.4% vs 29.7%;aOR 0.69;95%CI 0.64-0.74;P<0.001)。
- 神经功能良好存活 odds 更低(15.8% vs 21.6%;aOR 0.68;95%CI 0.61-0.76;P<0.001)。
- 急性复苏后存活 odds 更低(61.7% vs 69.5%;aOR 0.73;95%CI 0.67-0.79;P<0.001)。
- 上述关联在多项敏感性分析中一致,包括按除颤时间匹配的分析。
证据类型、等级与局限
- 证据类型:基于注册登记数据的倾向匹配分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文结论指出,与现行指南优先立即除颤相悖,约五分之一患者在除颤前接受肾上腺素,除颤前使用肾上腺素与更差的存活结局相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To determine the use of epinephrine (adrenaline) before defibrillation for treatment of in-hospital cardiac arrest due to a ventricular arrhythmia and examine its association with patient survival.
DESIGN: Propensity matched analysis.
SETTING: 2000-18 data from 497 hospitals participating in the American Heart Association’s Get With The Guidelines-Resuscitation registry.
PARTICIPANTS: Adults aged 18 and older with an index in-hospital cardiac arrest due to an initial shockable rhythm treated with defibrillation.
INTERVENTIONS: Administration of epinephrine before first defibrillation.
MAIN OUTCOME MEASURES: Survival to discharge; favorable neurological survival, defined as survival to discharge with none, mild, or moderate neurological disability measured using cerebral performance category scores; and survival after acute resuscitation (that is, return of spontaneous circulation for >20 minutes). A time dependent, propensity matched analysis was performed to adjust for confounding due to indication and evaluate the independent association of epinephrine before defibrillation with study outcomes.
RESULTS: Among 34 820 patients with an initial shockable rhythm, 7054 (20.3%) were treated with epinephrine before defibrillation, contrary to current guidelines. In comparison with participants treated with defibrillation first, participants receiving epinephrine first were less likely to have a history of myocardial infarction or heart failure, but more likely to have renal failure, sepsis, respiratory insufficiency, and receive mechanical ventilation before in-hospital cardiac arrest (standardized differences >10% for all). Treatment with epinephrine before defibrillation was strongly associated with delayed defibrillation (median 4 minutes v 0 minutes). In propensity matched analysis (6569 matched pairs), epinephrine before defibrillation was associated with lower odds of survival to discharge (22.4% v 29.7%; adjusted odds ratio 0.69; 95% confidence interval 0.64 to 0.74; P<0.001), favorable neurological survival (15.8% v 21.6%; 0.68; 0.61 to 0.76; P<0.001) and survival after acute resuscitation (61.7% v 69.5%; 0.73; 0.67 to 0.79; P<0.001). The above findings were consistent in a range of sensitivity analyses, including matching according to defibrillation time.
CONCLUSIONS: Contrary to current guidelines that prioritize immediate defibrillation for in-hospital cardiac arrest due to a shockable rhythm, one in five patients are treated with epinephrine before defibrillation. Use of epinephrine before defibrillation was associated with worse survival outcomes.
参考来源
- Evans E, Swanson MB, Mohr N, et al. Epinephrine before defibrillation in patients with shockable in-hospital cardiac arrest: propensity matched analysis. BMJ. 2021. PMID: 34759038. doi:10.1136/bmj-2021-066534
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。